Application no. and date | 10790565.5 (espacenet) (Federated) (European Patent Register), 20101214 | Patent/reg. no. and date | DK/EP 2515886, 20180411 | Publication date | 20121031 | Priority no. and date | EP 09180413, 20091222, EP 10154648, 20100225 | EP pub. no. and date |
EP 2515886 20121031 | Effective date | | Applicant/owner | Luye Pharma AG, Am Windfeld 35
83714 Miesbach, DE | Applicant ref. no. | P81801298DK00E | Inventor | SCHURAD, Björn, Michael-Huber-Weg 26
81667 München, DE, BECKERT, Thomas, Anton-Braith-Weg 30
88447 Birkenhard, DE, PRINZ, Heike, Malvenweg 16
82008 Unterhaching, DE, LINDER, Kristina, Uslauer Weg 6
83088 Kiefersfelden, DE | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/27 (2006.01) , A61K 31/445 (2006.01) , A61K 31/55 (2006.01) , A61K 9/70 (2006.01) | Title | Transdermalt terapeutisk system til indgivelse af rivastigmin eller derivater deraf | Int. application no. | EP2010069654 | Int. publication no. | WO2011076621 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|